HomeIrbesartanIrbesartan + Nifedipine

Does Irbesartan Interact with Nifedipine?

Irbesartan and Nifedipine have a minor drug interaction according to U.S. FDA drug labeling data. In vitro studies suggest CYP 2C9 inhibition, but in clinical studies nifedipine showed no clinically significant effect on irbesartan pharmacokinetics or pharmacodynamics. The mechanism involves cyp 2c9 inhibition (in vitro only). Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Irbesartan Class
Angiotensin 2 Receptor Blocker
Nifedipine Class
Dihydropyridine Calcium Channel Blocker
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Irbesartan and Nifedipine occurs because cyp 2c9 inhibition (in vitro only). Clinically, this means in vitro studies suggest cyp 2c9 inhibition, but in clinical studies nifedipine showed no clinically significant effect on irbesartan pharmacokinetics or pharmacodynamics. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Irbesartan and your doctor is considering prescribing Nifedipine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Irbesartan+💊 Nifedipine

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin 2 Receptor Blocker
Drug B class
Dihydropyridine Calcium Channel Blocker
Source
NLP:irbesartan

What this means in plain English

In vitro studies suggest CYP 2C9 inhibition, but in clinical studies nifedipine showed no clinically significant effect on irbesartan pharmacokinetics or pharmacodynamics.

What the FDA label says

"CYP 2C9 inhibition (in vitro only)"

📖 Source: NLP:irbesartan

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Irbesartan and Nifedipine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.